Tuberculosis in HIV-infected patients: a comprehensive review
Tóm tắt
Từ khóa
Tài liệu tham khảo
Ottenhoff, 1998, Novel human immunodeficiencies reveal the essential role of type-1 cytokines in immunity to intracellular bacteria, Immunol Today, 19, 491, 10.1016/S0167-5699(98)01321-8
Marchal, 1997, Pathophysiology and immunology of tuberculosis, Rev Mal Respir, 14, S19
Havlir, 1999, Current concepts. Tuberculosis in patients with human immunodeficiency virus infection, N Engl J Med, 340, 367, 10.1056/NEJM199902043400507
Garrait, 1997, Tuberculosis generates a microenvironment enhancing the productive infection of local lymphocytes by HIV, J Immunol, 159, 2824, 10.4049/jimmunol.159.6.2824
Whalen, 1995, Accelerated course of human immunodeficiency virus infection after tuberculosis, Am J Respir Crit Care Med, 151, 129, 10.1164/ajrccm.151.1.7812542
Dye, 1999, Consensus statement. Global burden of tuberculosis. Estimated incidence prevalence and mortality by country. Who Global Surveillance and Monitoring Project, JAMA, 282, 677, 10.1001/jama.282.7.677
Seng, 2002, Community study of the relative impact of HIV-1 and HIV-2 on intrathoracic tuberculosis, AIDS, 16, 1059, 10.1097/00002030-200205030-00013
Raviglione, 1997, Tuberculosis and HIV: current status in Africa, AIDS, 11, S115
Wood, 2000, Risk factors for developing tuberculosis in HIV-1 infected adults from communities with a low or very high incidence of tuberculosis, J AIDS, 23, 75
Perneger, 1995, Does the onset of tuberculosis in AIDS predict shorter survival? Results of a cohort study in 17 European countries over 13 years. AIDS in Europe Study Group, BMJ, 311, 1468, 10.1136/bmj.311.7018.1468
Corbett, 2002, HIV/AIDS and the control of other infectious diseases in Africa, Lancet, 359, 2177, 10.1016/S0140-6736(02)09095-5
Lucas, 1993, The mortality and pathology of HIV infection in a West Africa city, AIDS, 7, 1569, 10.1097/00002030-199312000-00005
Laurent, 2001, Epidemiology of HIV infection in sub-Saharan Africa, AIDS Rev, 3, 59
Rana, 2000, Autopsy study of HIV-1-positive and HIV-1-negative adult medical patients in Nairobi, Kenya, J AIDS, 24, 23
Institut de Veille Sanitaire (IVS), 1993, Surveillance de la tuberculose en France, Bull Epidemiol Hebd, 19, 86
Institut de Veille Sanitaire (IVS), 2001, Surveillance du SIDA en France. Situation au 30 septembre 2001, Bull Epidemiol Hebd, 47, 207
Geng, 2002, Changes in the transmission of tuberculosis in New York city from 1990 to 1999, N Engl J Med, 346, 1453, 10.1056/NEJMoa012972
Leonard, 2002, Increased survival of persons with tuberculosis and human immunodeficiency virus infection, 1991-2000, Clin Infect Dis, 34, 1002, 10.1086/339448
Decludt, 2002, Les cas de tuberculose déclarés en France 2000, Bull Epidemiol Hebd, 16, 68
Robert, 2002, Surveillance de la tuberculose à bacilles multirésistants en France en 1998, Bull Epidemiol Hebd, 16, 71
Daley, 1992, An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms, N Engl J Med, 326, 231, 10.1056/NEJM199201233260404
Perronne, 1988, Tuberculosis in patients infected with the human immunodeficiency virus, Presse Med, 17, 1479
Jones, 1993, Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infection, Am Rev Respir Dis, 148, 1292, 10.1164/ajrccm/148.5.1292
Perlman, 1997, Variation of chest radiographic patterns in pulmonary tuberculosis by degree of human immunodeficiency virus-related immunosuppression. The Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA). The AIDS Clinical Trials Group (ACTG), Clin Infect Dis, 25, 242, 10.1086/514546
Smith, 1994, Factors affecting the yield of acid-fast sputum smears in patients with HIV and tuberculosis, Chest, 106, 684, 10.1378/chest.106.3.684
Pitchenik, 1987, HTLV-III seropositivity and related disease among 71 consecutive patients in whom tuberculosis was diagnosed. A prospective study, Am Rev Respir Dis, 135, 875, 10.1164/arrd.1987.135.4.875
Dube, 1992, Tuberculosis meningitis in patients with and without human immunodeficiency virus infection, Am J Med, 93, 520, 10.1016/0002-9343(92)90579-Z
Leung, 1996, Pulmonary tuberculosis: comparison of CT findings in HIV-seropositive and HIV seronegative patients, Radiology, 198, 687, 10.1148/radiology.198.3.8628855
Bissuel, 1994, Fever of unknown origin in HIV-infected patients: a critical analysis of a retrospective series of 57 cases, J Intern Med, 236, 529, 10.1111/j.1365-2796.1994.tb00840.x
Bouza, 1993, Mycobacterium tuberculosis bacteremia in patients with and without human immunodeficiency virus infection, Arch Intern Med, 153, 496, 10.1001/archinte.1993.00410040062009
Shafer, 1989, Frequency of Mycobacterium tuberculosis bacteremia in patients with tuberculosis in area endemic for AIDS, Am Rev Respir Dis, 140, 1611, 10.1164/ajrccm/140.6.1611
Salzman, 1992, The role of bronchoscopy in the diagnosis of pulmonary tuberculosis in patients at risk for HIV infection, Chest, 102, 143, 10.1378/chest.102.1.143
Pangon, 1988, Retrospective bacteriological study of mycobacterial infections in patients with acquired immunodeficiency syndrome, Presse Med, 17, 945
Bradley, 1996, Clinical efficacy of the amplified Mycobacterium tuberculosis direct test for the diagnosis of pulmonary tuberculosis, Am J Respir Crit Care Med, 153, 1606, 10.1164/ajrccm.153.5.8630609
Dean, 2002, Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy, AIDS, 16, 75, 10.1097/00002030-200201040-00010
Tam, 1998, Rifapentine and isoniazid in the continuation phase of treating pulmonary tuberculosis; initial report, Am J Respir Crit Med, 157, 1726, 10.1164/ajrccm.157.6.9707037
Vernon, 1999, Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazid. Tuberculosis Trials Consortium, Lancet, 353, 1843, 10.1016/S0140-6736(98)11467-8
Chaisson, 1996, Six-month supervised intermittent tuberculosis therapy in Haitian patients with and without HIV infection, Am J Respir Crit Care Med, 154, 1034, 10.1164/ajrccm.154.4.8887603
El-Sadr, 1998, Evaluation of an intensive intermittent-induction regimen and short course duration of treatment for HIV-related pulmonary tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) and the AIDS Clinical trials Group (ACTG), Clin Infect Dis, 26, 1148, 10.1086/520275
Kassim, 1995, Two-year follow-up of persons with HIV-1- and HIV-2-associated pulmonary tuberculosis treated with short-course chemotherapy in West Africa, AIDS, 9, 1185, 10.1097/00002030-199510000-00011
Perriens, 1995, Pulmonary tuberculosis in HIV-infected patients in Zaire. A controlled trial of treatment for either 6 or 12 months, N Engl J Med, 332, 779, 10.1056/NEJM199503233321204
Pulido, 1997, Relapse of tuberculosis after treatment in human immunodeficiency virus-infected patients, Arch Intern Med, 157, 227, 10.1001/archinte.1997.00440230105014
Centers for Disease Control and Prevention, 1998, Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: principles of therapy and revised recommendations, MMWR, 47, 1
Centers for Disease Control and Prevention, 2000, Prevention and treatment of tuberculosis among patients infected with human immuodeficiency virus: principles of therapy and revised recommendations, MMWR, 49, 185
Pozniak, 1999, The treatment of tuberculosis in HIV-infected persons, AIDS, 13, 435, 10.1097/00002030-199903110-00001
Alwood, 1994, Effectiveness of supervised, intermittent therapy for tuberculosis in HIV-infected patients, AIDS, 8, 1103, 10.1097/00002030-199408000-00010
Nunn, 1992, Cohort study of human immunodeficiency virus infection in patients with tuberculosis in Nairobi, Kenya. Analysis of early (6-month) mortality, Am Rev Respir Dis, 146, 849, 10.1164/ajrccm/146.4.849
Jones, 1994, Prospective evaluation of antituberculosis therapy in patients with HIV infection, Am J Respir Crit Care Med, 150, 1499, 10.1164/ajrccm.150.6.7952606
Moreno, 2001, Treatment of tuberculosis in HIV-infected patients: safety and antiretroviral efficacy of the concomitant use of ritonavir and rifampin, AIDS, 15, 1185, 10.1097/00002030-200106150-00018
Lopez-Cortes, 2002, Pharmacokinetic interactions between efavirenz and rifampicin in HIV-infected patients with tuberculosis, Clin Pharmacokinet, 41, 681, 10.2165/00003088-200241090-00004
Molla, 1996, Ordered accumulation of mutations in HIV protease confers resistance to ritonavir, Nat Med, 2, 760, 10.1038/nm0796-760
Centers for Disease Control and Prevention, 1996, Clinical update: impact of HIV protease inhibitors on the treatment of HIV-infected tuberculosis patients with rifampin, MMWR, 45, 921
Borin, 1997, Pharmacokinetic study of the interaction between rifabutin and delaverdine mesylate in HIV-1 infected patients, Anti Viral Res, 35, 53, 10.1016/S0166-3542(97)00011-9
Munsiff, 1997, Rifampin monoresistant tuberculosis in New York City, 1993-1994, Clin Infect Dis, 25, 1465, 10.1086/516146
O'Brien, 1998, New tuberculosis drug development: how can we do better?, Am J Respir Crit Care Med, 157, 1705, 10.1164/ajrccm.157.6.1576
Rizdon, 1998, Risk factors for rifampin mono-resistant tuberculosis, Am J Respir Crit Care Med, 157, 1881, 10.1164/ajrccm.157.6.9712009
Sandman, 1999, Risk factors for rifampin-monoresistant tuberculosis: a case-control study, Am J Respir Crit Care Med, 159, 468, 10.1164/ajrccm.159.2.9805097
Patel, 1995, Drug malabsorption and resistance tuberculosis in HIV-infected patients, N Engl J Med, 332, 336, 10.1056/NEJM199502023320518
Peloquin, 1996, Low antituberculosis drug concentrations in patients with AIDS, Ann Pharmacother, 9, 919, 10.1177/106002809603000901
Nolan, 1995, Evolution of rifampin resistance in human immunodeficiency virus-associated tuberculosis, Am J Respir Crit Care Med, 152, 1067, 10.1164/ajrccm.152.3.7663785
Hawken, 1993, Increased recurrence of tuberculosis in HIV-1 infected patients in Kenya, Lancet, 342, 332, 10.1016/0140-6736(93)91474-Z
Perriens, 1991, Increased mortality and tuberculosis treatment failure rate among human immunodeficiency virus (HIV) seropositive compared with HIV seronegative patients with pulmonary tuberculosis treated with 'standard' chemotherapy in Kinshasa, Zaire, Am Rev Respir Dis, 144, 750, 10.1164/ajrccm/144.4.750
Fitzgerald, 2000, Effect of post-treatment isoniazid on prevention of recurrent tuberculosis in HIV-1-infected individuals: a randomised trial, Lancet, 356, 1470, 10.1016/S0140-6736(00)02870-1
Sonnenberg, 2001, Godfrey–Faussett. HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers, Lancet, 358, 1687, 10.1016/S0140-6736(01)06712-5
Connolly, 1999, Relapse and mortality among HIV-infected and uninfected patients with tuberculosis successfully treated with twice weekly directly observed therapy in rural South Africa, AIDS, 13, 1543, 10.1097/00002030-199908200-00015
Crump, 1998, Miliary tuberculosis with paradoxical expansion of intracranial tuberculomas complicating human immunodeficiency virus infection in a patient receiving highly active antiretroviral therapy, Clin Infect Dis, 26, 1008, 10.1086/517636
Kunimoto, 1999, Immune mediated 'HAART' attack during treatment for tuberculosis. Highly active antiretroviral therapy, Int J Tuberc Lung Dis, 3, 944
Narita, 1998, Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS, Am J Respir Crit Care Med, 158, 157, 10.1164/ajrccm.158.1.9712001
Shelburne, 2002, Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy, Medicine, 81, 213, 10.1097/00005792-200205000-00005
Race, 1998, Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 disease, Lancet, 351, 252, 10.1016/S0140-6736(97)04352-3
Martinez, 1998, High incidence of herpes zoster in patients with AIDS soon after therapy with protease inhibitors, Clin Infect Dis, 27, 1510, 10.1086/515019
Karavellas, 1998, Immune recovery vitritis associated with inactive cytomegalovirus retinitis, Arch Opthalmol, 116, 169, 10.1001/archopht.116.2.169
Jacobson, 1997, Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy, Lancet, 349, 1443, 10.1016/S0140-6736(96)11431-8
Foudraine, 1999, Immunopathology as a result of highly active antiretroviral therapy in HIV-1 infected patients, AIDS, 13, 177, 10.1097/00002030-199902040-00005
Memain, 2001, Paradoxical reactions due to immune restoration during Cryptococcus neoformans infection in AIDS [abstract 674]
Kovacs, 2000, Drug therapy: prophylaxis against opportunistic infections in patients with human immunodeficiency virus infection, N Engl J Med, 342, 1416, 10.1056/NEJM200005113421907
Gourevitch, 1999, Effectiveness of isoniazid chemoprophylaxis for HIV-infected drug users at high risk for active tuberculosis, AIDS, 22, 2069, 10.1097/00002030-199910220-00009
Jansa, 1998, Influence of the human immunodeficiency virus in the incidence of tuberculosis in a cohort of intravenous drug users: effectiveness of anti-tuberculosis chemoprophylaxis, Int J Tuberc Lung Dis, 2, 140
Graham, 1996, Effect of isoniazid chemoprophylaxis on HIV-related mycobacterial disease, Arch Intern Med, 156, 889, 10.1001/archinte.1996.00440080089010
Halsey, 1998, Randomized trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection, Lancet, 351, 786, 10.1016/S0140-6736(97)06532-X
Centers for Disease Control and Prevention, 2001, Update: fatal and severe liver injuries associated with rifampin and pyrazinamide for latent tuberculosis infection, and revisions in. American Thoracic Society/CDC recommendation—United States, 2001, MMWR, 50, 733
Badri, 2002, Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study, Lancet, 359, 2059, 10.1016/S0140-6736(02)08904-3
Santoro-Lopes, 2002, Reduced risk of tuberculosis among Brazilian patients with advanced human immunodeficiency virus infection treated with highly active antiretroviral therapy, Clin Infect Dis, 34, 543, 10.1086/338641
World Health Organization/UNAIDS, 1999, Preventive therapy against tuberculosis in people living with HIV, Wkly Epidemiol Rec, 74, 385